Stay updated on Tucatinib Combo in HER2+ LMD Clinical Trial
Sign up to get notified when there's something new on the Tucatinib Combo in HER2+ LMD Clinical Trial page.

Latest updates to the Tucatinib Combo in HER2+ LMD Clinical Trial page
- Check6 days agoChange DetectedVersion v3.6.0 was added, replacing v3.5.5. The entry also notes that no longer looking for participants, indicating recruitment has ended.SummaryDifference0.5%

- Check13 days agoChange DetectedThe page history now records a new revision, v3.5.5, replacing the previous v3.5.4. This signals a minor update to the page release.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedRecord History now shows Revision: v3.5.4, replacing Revision: v3.5.3. This reflects a site-wide release update rather than any change to the study record itself.SummaryDifference0.1%

- Check56 days agoChange DetectedA site revision/version indicator on the record history page was updated from v3.5.2 to v3.5.3, reflecting a platform change rather than a change to the clinical trial record contents.SummaryDifference0.1%

- Check64 days agoChange DetectedAdded Revision: v3.5.2; Removed Revision: v3.5.0.SummaryDifference0.1%

- Check92 days agoChange DetectedRevision history updated: added v3.5.0 and removed v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Tucatinib Combo in HER2+ LMD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tucatinib Combo in HER2+ LMD Clinical Trial page.